Aleksandra Ochnik
Research Fellow
Biomedical Science
University of Adelaide
Australia
Biography
Aleksandra Ochnik has completed an international Susan G. Komen postdoctoral research and training fellowship in the US at the Masonic Cancer Center, University of Minnesota and a Cancer Institute of NSW Sydney Vital Translational Cancer Research Centre preclinical postdoctoral fellowship at the Kolling Institute of Medical Research/University of Sydney. Her postdoctoral research has focused primarily on growth factor receptor signaling in breast cancer, specifically type I insulin-like growth factor receptor (IGF1R) with the aim understanding the involvement IGF1R signalling downstream mediators and co-related factors for the development of more effective IGF1R-directed therapies. Currently she is undertaking a research fellowship in Professor Shudong Wang's laboratory studying and testing novel classes of kinase inhibitors against haematological and solid tumours for future clinical translation.
Research Interest
IGF1R Growth Factor Receptor Breast Cancer IGF1R signalling Solid tumours
Publications
-
Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo
-
Amplified in breast cancer regulates transcription and translation in breast cancer cells
-
Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer
